.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Prednisolone sodium phosphate - Generic Drug Details

« Back to Dashboard
Prednisolone sodium phosphate is the generic ingredient in thirteen branded drugs marketed by Vintage, Pharm Assoc, Pharmafair, Vintage Pharms, Watson Labs, Concordia Pharms Inc, Merck, Schering, Alcon Pharms Ltd, Amneal Pharms, Medicis Pharms, Novartis, Seton Pharm, Akorn, Edenbridge Pharms, Bausch And Lomb, Sola Barnes Hind, Mylan Pharms Inc, We Pharms, Nesher Pharms, Hi Tech Pharma, Paddock Llc, Wockhardt, and Mission Pharma, and is included in forty-one NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

This ingredient has seven patent family members in five countries.

There are eighty-five drug master file entries for prednisolone sodium phosphate. Twenty-four suppliers are listed for this compound.

Summary for Generic Name: prednisolone sodium phosphate

Tradenames:13
Patents:1
Applicants:24
NDAs:41
Drug Master File Entries: see list85
Suppliers / Packagers: see list24
Bulk Api Vendors: see list47
Clinical Trials: see list1,372
Patent Applications: see list3,509
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:prednisolone sodium phosphate at DailyMed

Pharmacology for Ingredient: prednisolone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sola Barnes Hind
PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC084168-001Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
Bausch And Lomb
SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate; sulfacetamide sodium
SOLUTION/DROPS;OPHTHALMIC074449-001Dec 29, 1995RXYes► subscribe► subscribe
Pharm Assoc
PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate
SOLUTION;ORAL076123-001Dec 23, 2002DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: prednisolone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Pharms Inc
ORAPRED ODT
prednisolone sodium phosphate
TABLET, ORALLY DISINTEGRATING;ORAL021959-001Jun 1, 20065,178,878► subscribe
Seton Pharm
PEDIAPRED
prednisolone sodium phosphate
SOLUTION;ORAL019157-001May 28, 19864,448,774► subscribe
Concordia Pharms Inc
ORAPRED ODT
prednisolone sodium phosphate
TABLET, ORALLY DISINTEGRATING;ORAL021959-002Jun 1, 20065,178,878► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: prednisolone sodium phosphate

Country Document Number Estimated Expiration
European Patent Office1133282► subscribe
Japan2002530322► subscribe
Australia1922000► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc